Three Dimensional Paper Sensor Could Test for Disease
|
By LabMedica International staff writers Posted on 15 Mar 2012 |

Image: Origami-inspired paper sensor can be easily assembled by hand. It may soon be able to inexpensively test for diseases like malaria and HIV (Photo courtesy of Alex Wang).
Origami-inspired paper sensor could test for malaria and Human Immunodeficiency Virus (HIV) for less than USD 0.10. Sensors can be printed out on an office printer, and take less than a minute to assemble.
These low-cost, "point-of-care" sensors could be useful in the developing world, where resources are often lacking to pay for lab-based tests, and where, even if the money is available, there infrastructure does not exist to transport biological samples to the lab.
Inspired by the paper-folding art of origami, chemists at The University of Texas at Austin (Texas; USA) have developed a 3-D paper sensor that may be able to test for diseases such as malaria and HIV.
One-dimensional paper sensors, such as those used in pregnancy tests, are already common but have limitations. The folded, 3-D sensors, developed by Richard Crooks, the Robert A. Welch professor of chemistry and doctoral student Hong Liu, can test for more substances in a smaller surface area and provide results for more complex tests.
"Anybody can fold them up," said Prof. Crooks. "You don't need a specialist, so you could easily imagine an [non-governmental organization] NGO with some volunteers folding these things up and passing them out. They're easy to produce as well, so the production could be shifted to the clientele as well. They don't need to be made in the developed world."
Prof. Crooks said that the principles underlying the sensor, which have been successfully tested on glucose and a common protein, are related to the home pregnancy test. A hydrophobic material, such as wax or photo resist, is laid down into tiny canyons on chromatography paper. It channels the sample to be tested—urine, blood, or saliva, for instance—to spots on the paper where test reagents have been embedded.
If the sample has whatever targets the sensor is designed to detect, it will react in an easily detectable manner. It might turn a specific color for example or fluoresce under a UV light. Then it can be read by eye.
Related Links:
The University of Texas at Austin
These low-cost, "point-of-care" sensors could be useful in the developing world, where resources are often lacking to pay for lab-based tests, and where, even if the money is available, there infrastructure does not exist to transport biological samples to the lab.
Inspired by the paper-folding art of origami, chemists at The University of Texas at Austin (Texas; USA) have developed a 3-D paper sensor that may be able to test for diseases such as malaria and HIV.
One-dimensional paper sensors, such as those used in pregnancy tests, are already common but have limitations. The folded, 3-D sensors, developed by Richard Crooks, the Robert A. Welch professor of chemistry and doctoral student Hong Liu, can test for more substances in a smaller surface area and provide results for more complex tests.
"Anybody can fold them up," said Prof. Crooks. "You don't need a specialist, so you could easily imagine an [non-governmental organization] NGO with some volunteers folding these things up and passing them out. They're easy to produce as well, so the production could be shifted to the clientele as well. They don't need to be made in the developed world."
Prof. Crooks said that the principles underlying the sensor, which have been successfully tested on glucose and a common protein, are related to the home pregnancy test. A hydrophobic material, such as wax or photo resist, is laid down into tiny canyons on chromatography paper. It channels the sample to be tested—urine, blood, or saliva, for instance—to spots on the paper where test reagents have been embedded.
If the sample has whatever targets the sensor is designed to detect, it will react in an easily detectable manner. It might turn a specific color for example or fluoresce under a UV light. Then it can be read by eye.
Related Links:
The University of Texas at Austin
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more
Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. However, few investigations have directly examined blood plasma vitamin C in relation to brain... Read more
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer
Human papillomavirus (HPV)-associated head and neck cancers are frequently treated with surgery, but some patients experience recurrence due to residual microscopic disease. Postoperative decisions about... Read more
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read morePathology
view channel
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more




.jpg)



